SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-22-259634
Filing Date
2022-10-07
Accepted
2022-10-07 16:30:12
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B4 d383770d424b4.htm 424B4 1176968
2 GRAPHIC g383770g05v33.jpg GRAPHIC 129277
3 GRAPHIC g383770g11d11.jpg GRAPHIC 132129
4 GRAPHIC g383770g13a00.jpg GRAPHIC 122851
5 GRAPHIC g383770g22b30.jpg GRAPHIC 74160
6 GRAPHIC g383770g22z92.jpg GRAPHIC 112079
7 GRAPHIC g383770g23a23.jpg GRAPHIC 88202
8 GRAPHIC g383770g23s23.jpg GRAPHIC 107760
9 GRAPHIC g383770g24x25.jpg GRAPHIC 78108
10 GRAPHIC g383770g31v63.jpg GRAPHIC 80309
11 GRAPHIC g383770g36n42.jpg GRAPHIC 316344
12 GRAPHIC g383770g39d73.jpg GRAPHIC 93340
13 GRAPHIC g383770g80r72.jpg GRAPHIC 178075
14 GRAPHIC g383770g92x08.jpg GRAPHIC 44812
15 GRAPHIC g383770g96o04.jpg GRAPHIC 105570
  Complete submission text file 0001193125-22-259634.txt   3446764
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-267730 | Film No.: 221301066
SIC: 2834 Pharmaceutical Preparations